BML Investment Partners, L.P.

13F Holdings History for AN2 Therapeutics, Inc. - Common Stock (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 427K shares
Security Ownership: 1.4%

BML Investment Partners, L.P. ownership in AN2 Therapeutics, Inc. Common Stock (ANTX)

2025-06-18 - BML Investment Partners, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 427K shares of AN2 Therapeutics, Inc. Common Stock (ANTX). This represents 1.4% percent ownership of the company. In their previous filing dated 2025-05-30, BML Investment Partners, L.P. had reported owning 3.22M shares, indicating a decrease of -86.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BML Investment Partners, L.P.	1.4%	-84.5%	$551K	427K	-2,789,991	-86.7%	$1.29	13D/A	6/17/2025	18 Jun 2025 11:08:01
BML Investment Partners, L.P.	10.7%	-44.2%	$4.15M	3.22M	-2,532,009	-44%	$1.29	13D/A	5/28/2025	30 May 2025 17:46:45
BML Investment Partners, L.P.	19.1%	-0.53%	$7.82M	5.75M			$1.36	13D	5/7/2025	7 May 2025 10:27:57
BML Investment Partners, L.P.	19.2%		$7.82M	5.75M			$1.36	13G/A	12/31/2024	13 Feb 2025 16:28:34